XML 52 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Oct. 31, 2023
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated condensed statements of cash flows was as follows:
October 31,
2023		January 31,
2023
(in thousands)
Cash and cash equivalents$367,012 $264,162 
Restricted cash30,400 30,400 
Total cash, cash equivalents, and restricted cash$397,412 $294,562 
Restrictions on Cash and Cash Equivalents
The reconciliation of cash, cash equivalents, and restricted cash to amounts presented in the consolidated condensed statements of cash flows was as follows:
October 31,
2023		January 31,
2023
(in thousands)
Cash and cash equivalents$367,012 $264,162 
Restricted cash30,400 30,400 
Total cash, cash equivalents, and restricted cash$397,412 $294,562 
Schedule of Short-Term Investments As of January 31, 2023, short-term investments consisted of the following:
January 31, 2023
Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
(in thousands)
U.S. Treasury Securities$105,415 $— $(449)$104,966 
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis As of January 31, 2023, the Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
Fair Value Measured as of January 31, 2023
Level 1Level 2Level 3Total
(in thousands)
Assets
Money market funds$133,979 $— $— $133,979 
U.S. Treasury securities— 104,966 — 104,966 
Total financial assets$133,979 $104,966 $— $238,945 
Schedule of Changes in the Fair Value of the Company's Level 3 Financial Instruments The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments for the nine months ended October 31, 2022:
Private placement warrant liability
ViriCiti Earnout liability
(in thousands)
Fair value as of January 31, 2022$(25)$(5,993)
Change in fair value included in other income (expense), net(23)— 
Effect of foreign currency translation— 656 
Reclassification of warrants to stockholders’ equity (deficit) due to exercise48 — 
Fair value as of October 31, 2022$— $(5,337)